JSB market research:Cell-based Assays Market by Product report - Global Forecast to 2018
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Cell</strong>-<strong>based</strong> <strong>Assays</strong> <strong>Market</strong> <strong>by</strong> <strong>Product</strong> [Reagents & Assay Kits<br />
(Cy<strong>to</strong><strong>to</strong>xicity, GPCR), <strong>Cell</strong> lines, Plate Readers, HCS, HTS,<br />
Software & Assay Development Services], Application (Drug<br />
Discovery, ADMET), End-user (Pharmaceutical, CRO) - <strong>Global</strong><br />
<strong>Forecast</strong> <strong>to</strong> <strong>2018</strong><br />
On 22 st May 2014<br />
The <strong>market</strong> for cell-<strong>based</strong> assays is driven <strong>by</strong> the preference over biochemical assays and<br />
animal models and the emergent 3D cell-<strong>based</strong> assay techniques in cell-<strong>based</strong> assays.<br />
There has been a substantial rise in the costs <strong>to</strong> develop a new drug in recent years. This is<br />
specially observed when a new compound enters animal testing. The use of animals in<br />
experimentation is becoming dearer, due <strong>to</strong> limitations such as high costs involved in breeding<br />
and acquisition of animals, due <strong>to</strong> the complexity of procedures involved in the in vivo testing,<br />
and several other ethical issues and legal issues associated with it. Moreover the traditional<br />
biochemical assays also posses many limitations. To counteract these issues there has been a<br />
paradigm shift <strong>to</strong>wards the use of cell-<strong>based</strong> assays.<br />
The consumables formed the largest product segment of the <strong>to</strong>tal cell-<strong>based</strong> assays <strong>market</strong> in<br />
2013, which includes assay kits and reagents, microplates and cell lines. The largest<br />
contribution of consumables was attributed <strong>to</strong> the large volume <strong>market</strong> of reagents and assay<br />
kits; where most of the innovation is taking place. Drug discovery was the most prominent<br />
application of cell-<strong>based</strong> assays. Within drug discovery, lead identification and optimization<br />
accounted for the largest share in 2013. With respect <strong>to</strong> end users, the pharmaceutical and<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
iotechnology companies commanded the largest share in 2013. These industries are focusing<br />
on screening extensive libraries of compounds that could become leads for potential drug<br />
candidates. The screening process has helped the pharmaceutical companies <strong>to</strong> run more cost<br />
and time efficient methods.<br />
For accurate results, the low cost label-free technology in cell <strong>based</strong> assays has emerged as a<br />
momen<strong>to</strong>us technology that has been driving the growth of cell-<strong>based</strong> assay <strong>market</strong>. With the<br />
advancement in the cell stem cell culture, induced pluripotent stem cells will be emerging in<br />
near future. With the increasing demand of emergent 3D cell-<strong>based</strong> assay, it is estimated <strong>to</strong> be<br />
the fastest growing technology in the next five years.<br />
North America accounted for the largest share of the global cell-<strong>based</strong> assay <strong>market</strong> in 2013.<br />
The presence of a large number of <strong>market</strong> players along with government funding for drug<br />
discovery and increasing number of public-private partnerships are the fac<strong>to</strong>rs driving the<br />
North American cell-<strong>based</strong> assay <strong>market</strong>. Countries such as India and China serve as new<br />
revenue pockets for the cell-<strong>based</strong> assay <strong>market</strong>. Healthcare reforms, government initiatives,<br />
growing awareness and increasing investments in drug discovery are encouraging the rising<br />
acceptance and adoption of the cell-<strong>based</strong> assay technology in these regions. The emerging<br />
countries in Asia such as China and India will register high growth in the coming years; this can<br />
be attributed <strong>to</strong> the low development costs offered <strong>by</strong> these nations. Moreover, clinical<br />
<strong>research</strong> organizations are growing at fastest rate and more inclined <strong>to</strong> set their pace in these<br />
nations.<br />
The grey areas while estimating the <strong>market</strong> size was the overlapping nature of the products and<br />
technology while segregating them <strong>based</strong> on evaluation of endpoints involved. As there is a thin<br />
line between products and technology used, both were included while estimating the patient<br />
moni<strong>to</strong>ring <strong>market</strong>.<br />
From an insight perspective, this <strong>research</strong> <strong>report</strong> focuses on the qualitative data, <strong>market</strong> size,<br />
share, growth of various segments and sub-segments, competitive landscape, and company<br />
profiles. The qualitative data covers various levels of industry analysis such as <strong>market</strong> dynamics<br />
(drivers, restraints, opportunities, and threats). The <strong>report</strong> also offers <strong>market</strong> shares, sizes, and<br />
related growth of various segments in the industry. It also focuses on the emerging and highgrowth<br />
segments of cell-<strong>based</strong> assay <strong>market</strong>, high-growth regions, and the initiatives of<br />
respective governments.<br />
The competitive landscape covers the growth strategies adopted <strong>by</strong> industry players in the last<br />
three years. The company profiles comprise the basic views on the key players in the cell-<strong>based</strong><br />
assay <strong>market</strong>, product portfolios, developments, and strategies adopted <strong>by</strong> <strong>market</strong> players <strong>to</strong><br />
maintain and increase their <strong>market</strong> shares in the near future. The above mentioned <strong>market</strong><br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
esearch data, current <strong>market</strong> size, and forecast of future trends will help the key players and<br />
new entrants <strong>to</strong> make the necessary decisions regarding product offerings, geographic focus,<br />
change in approach, R&D investments for innovations in products and technologies, and levels<br />
of output in order <strong>to</strong> remain successful.<br />
Table of content:<br />
1 Introduction (Page No. - 19)<br />
1.1 Objectives of the Study<br />
1.2 Report Description<br />
1.3 <strong>Market</strong>s Covered<br />
1.4 Stakeholders<br />
1.5 <strong>Market</strong> Scope<br />
1.6 Research Methodology<br />
1.6.1 <strong>Market</strong> Size Estimation<br />
1.6.2 <strong>Market</strong> Crackdown & Data Triangulation<br />
1.6.3 Key Data From Secondary Sources<br />
1.6.4 Key Data Points From Primary Sources<br />
1.6.5 Assumptions<br />
2 Summary<br />
(Page No. - 32)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
3 Premium Insights (Page No. - 36)<br />
3.1 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong><br />
3.2 <strong>Market</strong> Dynamics<br />
3.3 Snapshot of the <strong>Market</strong><br />
3.4 Consumables & Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong><br />
3.5 Geographic Analysis<br />
3.6 Application <strong>Market</strong><br />
3.7 End User <strong>Market</strong><br />
4 <strong>Market</strong> Overview (Page No. - 43)<br />
4.1 Introduction<br />
4.2 <strong>Market</strong> Dynamics<br />
4.2.1 Drivers<br />
4.2.1.1 Significant Advantages of <strong>Cell</strong>-Based <strong>Assays</strong> Over Conventional Techniques Provide Ideal<br />
Solution For A Range of Research & Commercial Applications<br />
4.2.1.2 Government Funding and Public-Private Partnerships Support <strong>Cell</strong>-Based Research<br />
Activities<br />
4.2.1.3 Drug Discovery, Major Driver For <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong><br />
4.2.1.4 Implementation of Hts and Au<strong>to</strong>mation Techniques Accelerates the Drug Discovery<br />
Process<br />
4.2.2 Restraints<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
4.2.2.1 Shortage of Skilled Experts & High Instrument Costs Have A Negative Impact<br />
4.2.2.2 Skepticism About Long-Term Benefits of Reporter Assay Kits May Affect their Adoption<br />
4.2.2.3 Intellectual Property Rights Issues Restrict Innovations in the <strong>Market</strong><br />
4.2.3 Opportunities<br />
4.2.3.1 Asian <strong>Market</strong> Presents High-Growth Opportunities<br />
4.2.3.2 Need <strong>to</strong> De-Risk Early-Phase Drug Discovery Reinforces <strong>Cell</strong>-Based <strong>to</strong>xicity Screening<br />
4.2.3.3 Developments in High-Content Screening and Software <strong>to</strong> Transform <strong>Cell</strong>-Based<br />
Screening<br />
4.2.4 Trends<br />
4.2.4.1 Use of Stem <strong>Cell</strong>s & 3d Culture Defines the Future of the <strong>Market</strong><br />
4.2.4.2 Assay Development and Assay Screening Services Are the Most Prominent Trend<br />
4.2.4.3 Label-Free Technologies Are Set <strong>to</strong> Transform the <strong>Market</strong><br />
4.3 Burning Issues & Challenges<br />
4.3.1 Consistent Supply of <strong>Cell</strong>s Creates A Bottleneck<br />
4.3.2 New Technologies Call For Assay Optimization<br />
4.4 Winning Imperatives<br />
4.4.1 Assay Multiplexing<br />
4.4.2 Assay Miniaturization & Microfluidics<br />
4.5 Porters Five Forces Analysis<br />
4.5.1 Threat From New Entrants<br />
4.5.2 Threat From Substitutes<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
4.5.3 Competi<strong>to</strong>rs Rivalry<br />
4.5.4 Bargaining Power of Suppliers<br />
4.5.5 Bargaining Power of Buyers<br />
4.6 <strong>Market</strong> Share Analysis<br />
5 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong> (Page No. - 63)<br />
5.1 Introduction<br />
5.2 Consumables<br />
5.2.1 Reagents & Assay Kits<br />
5.2.1.1 <strong>Cell</strong> Growth <strong>Assays</strong><br />
5.2.1.2 <strong>Cell</strong> Death <strong>Assays</strong><br />
5.2.1.3 Second Messenger <strong>Assays</strong><br />
5.2.1.4 Reporter Gene <strong>Assays</strong><br />
5.2.1.5 Other <strong>Assays</strong><br />
5.2.2 Microplates<br />
5.2.3 <strong>Cell</strong> Lines<br />
5.2.3.1 Immortalized <strong>Cell</strong> Lines<br />
5.2.3.2 Primary <strong>Cell</strong> Lines<br />
5.2.3.3 Stem <strong>Cell</strong> Lines<br />
5.2.4 Other Consumables<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
5.3 Instruments<br />
5.3.1 Detection & Screening Instruments<br />
5.3.1.1 Microplate Readers<br />
5.3.1.2 Flow Cy<strong>to</strong>meters<br />
5.3.1.3 Fluorescent Microscopes<br />
5.3.1.4 High Content Screening Instruments<br />
5.3.1.5 Label-Free Detection Instruments<br />
5.3.1.6 Other Detection and Screening Instruments<br />
5.3.2 Au<strong>to</strong>mation & High Throughput Screening Instruments<br />
5.4 Software<br />
5.5 Services<br />
6 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application (Page No. - 109)<br />
6.1 Introduction<br />
6.2 Basic Research<br />
6.3 Drug Discovery<br />
6.3.1 Target Identification and Validation<br />
6.3.2 Lead Identification & Optimization<br />
6.4 Absorption, Distribution, Metabolism & Excretion (Adme) Studies<br />
6.5 Predictive Toxicology<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
6.6 Other Applications<br />
7 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User (Page No. - 126)<br />
7.1 Introduction<br />
7.2 Pharmaceutical & Biotechnology Companies<br />
7.3 Academic & Government Institutions<br />
7.4 Contract Research Organizations (CRO)<br />
7.5 Other End Users (Hospitals/Clinical Labs, Food/ Agriculture Industries & Environmental<br />
Labs)<br />
8 <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography (Page No. - 136)<br />
8.1 Introduction<br />
8.2 North America<br />
8.2.1 Emphasis on Technological Advancements Drives the U.S. <strong>Market</strong><br />
8.2.2 Research Networks in Canada <strong>to</strong> Boost the <strong>Market</strong><br />
8.3 Europe<br />
8.3.1 Decline in Venture Capitalist Investments in Early Drug Discovery Shifts the Burden <strong>to</strong><br />
Public Funding<br />
8.3.2 Public-Private Partnerships <strong>to</strong> Accelerate Drug Discovery Process in European Union<br />
8.4 Asia<br />
8.4.1 Stem <strong>Cell</strong> Research in Japan<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
8.4.2 Drug Discovery Outsourcing Fuels the <strong>Market</strong> Growth in China and India<br />
8.5 ROW<br />
9 Competitive Landscape (Page No. - 179)<br />
9.1 Introduction<br />
9.2 New <strong>Product</strong> Launch<br />
9.3 Agreements, Collaborations & Partnerships<br />
9.4 Acquisitions<br />
9.5 Others<br />
10 Company Profiles (Page No. - 188)<br />
10.1 Bec<strong>to</strong>n, Dickinson and Company<br />
10.2 <strong>Cell</strong> Signaling Technology<br />
10.3 Cisbio Bioassays (Argos Soditic)<br />
10.4 Danaher Corporation<br />
10.5 Discoverx<br />
10.6 EMD Millipore (A Subsidiary of Merck Kgaa)<br />
10.7 Ge Healthcare (Subsidiary of General Electric Company)<br />
10.8 Life Technologies (Thermo Fisher Scientific)<br />
10.9 Perkinelmer, Inc.<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
10.10 Promega Corporation<br />
*Details on Business Overview, Financials, <strong>Product</strong> & Services, Key Strategy, & Recent<br />
Developments Might Not Be Captured in Case of Unlisted Companies.<br />
List of Tables<br />
Table 1 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 2 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 3 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 4 <strong>Global</strong> Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 5 Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 6 <strong>Global</strong> Reagents & Assay Kits <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 7 Reagents & Assay Kits <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong><br />
($Million)<br />
Table 8 <strong>Cell</strong> Growth <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 9 <strong>Cell</strong> Death <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 10 Second Messenger <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 11 Reporter Gene <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 12 Other <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 13 Microplates <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 14 <strong>Global</strong> <strong>Cell</strong> Lines <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Table 15 <strong>Cell</strong> Lines <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 16 Other Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 17 <strong>Global</strong> Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 18 Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 19 <strong>Global</strong> Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>,<br />
2011<strong>2018</strong> ($Million)<br />
Table 20 Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 21 Microplate Readers <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 22 Flow Cy<strong>to</strong>meters <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 23 Fluorescent Microscopes <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong><br />
($Million)<br />
Table 24 High Content Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 25 Label-Free Detection Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 26 Other Detection & Screening Instruments For <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By<br />
Geography, 2011<strong>2018</strong> ($Million)<br />
Table 27 Au<strong>to</strong>mation & Hts Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong><br />
($Million)<br />
Table 28 Software <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 29 Services <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 30 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2011<strong>2018</strong> ($Million)<br />
Table 31 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Basic Research, By Geography, 2011<strong>2018</strong> ($Million)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Table 32 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Drug Discovery, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 33 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Drug Discovery, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 34 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Target Identification & Validation, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 35 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Lead Identification & Optimization, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 36 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Adme Studies, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 37 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Predictive Toxicology, By Geography, 2011<strong>2018</strong><br />
($Million)<br />
Table 38 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Other Applications, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 39 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Table 40 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Pharmaceutical & Biotechnology Companies, By<br />
Geography, 2011<strong>2018</strong> ($Million)<br />
Table 41 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Academic & Government Institutions, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 42 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Contract Research Organizations, By Geography,<br />
2011<strong>2018</strong> ($Million)<br />
Table 43 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> For Other End Users, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 44 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Table 45 North America: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 46 North America: Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>, 2011-<strong>2018</strong><br />
($Million)<br />
Table 47 North America: Assay Kits & Reagents <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type,<br />
2011<strong>2018</strong> ($Million)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Table 48 North America: Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 49 North America: Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By<br />
<strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 50 North America: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2011<strong>2018</strong> ($Million)<br />
Table 51 North America: Drug Discovery <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 52 North America: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Table 53 Europe: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 54 Europe: Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 55 Europe: Assay Kits & Reagents <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 56 Europe: Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 57 Europe: Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>,<br />
2011<strong>2018</strong> ($Million)<br />
Table 58 Europe: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2011<strong>2018</strong> ($Million)<br />
Table 59 Europe: Drug Discovery <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 60 Europe: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Table 61 Asia: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 62 Asia: Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 63 Asia: Assay Kits & Reagents <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 64 Asia: Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Table 65 Asia: Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>,<br />
2011<strong>2018</strong> ($Million)<br />
Table 66 Asia: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2011<strong>2018</strong> ($Million)<br />
Table 67 Asia: Drug Discovery <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 68 Asia: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Table 69 ROW: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 70 ROW: Consumables <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>, 2011<strong>2018</strong> ($Million)<br />
Table 71 ROW: Assay Kits & Reagents <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong><br />
($Million)<br />
Table 72 ROW: Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 73 ROW: Detection & Screening Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, By <strong>Product</strong>,<br />
2011<strong>2018</strong> ($Million)<br />
Table 74 ROW: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2011<strong>2018</strong> ($Million)<br />
Table 75 ROW: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Type, 2011<strong>2018</strong> ($Million)<br />
Table 76 ROW: <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Table 77 New <strong>Product</strong> Launches, 20122014<br />
Table 78 Agreements, Partnerships & Collaborations, 20112013<br />
Table 79 Acquistions, 20112014<br />
Table 80 Other Developments, 20122013<br />
Table 81 Bec<strong>to</strong>n, Dickinson and Company, By Segment, 20112013 ($Million)<br />
Table 82 Danaher Corporation: Total Revenue, By Segment, 20112013 ($Million)<br />
Table 83 Merck Kgaa: Total Revenue, 20112013 ($Million)<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Table 84 General Electric: Total Revenue, By Seg<br />
List of Figures:<br />
Figure 1 <strong>Forecast</strong> Model<br />
Figure 2 <strong>Market</strong> Size Estimation Methodology & Triangulation<br />
Figure 3 Data Triangulation Methodology<br />
Figure 4 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2013 & <strong>2018</strong><br />
Figure 5 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Geography, 2011<strong>2018</strong> ($Million)<br />
Figure 6 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, 2013 ($Million)<br />
Figure 7 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> Dynamics<br />
Figure 8 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> Snapshot, 2013 ($Million)<br />
Figure 9 Consumables & Instruments <strong>Market</strong> For <strong>Cell</strong>-Based <strong>Assays</strong>, 2013 ($Million)<br />
Figure 10 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, Geographic Analysis, By <strong>Product</strong>, 2013 ($Million)<br />
Figure 11 Opportunity Matrix: <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong> By Application, 2013<br />
Figure 12 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2013 Vs <strong>2018</strong> ($Million)<br />
Figure 13 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>: Porters Five Forces Analysis<br />
Figure 14 <strong>Cell</strong>-Based <strong>Assays</strong>, Revenue <strong>Market</strong> Share Analysis, By Key Players, 2013<br />
Figure 15 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By <strong>Product</strong>, 2013 ($Million)<br />
Figure 16 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By Application, 2013 ($Million)<br />
Figure 17 <strong>Cell</strong>-Based Assay Applications in Drug Discovery Stages<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/
Figure 18 <strong>Global</strong> <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, By End User, 2011<strong>2018</strong> ($Million)<br />
Figure 19 <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Product</strong> Lifecycle, By Geography<br />
Figure 20 Key Growth Strategies, <strong>Cell</strong>-Based <strong>Assays</strong> <strong>Market</strong>, 20112014<br />
For more related <strong>report</strong>:<br />
http://www.jsb<strong>market</strong><strong>research</strong>.com/healthcare-medical/r-MediPoint-Companion-Diagnostic-<br />
Tests-in-Oncology-<strong>Global</strong>-Analysis-and-<strong>Market</strong>-<strong>Forecast</strong>s-110214<br />
http://www.jsb<strong>market</strong><strong>research</strong>.com/healthcare-medical/r-<strong>Global</strong>-Diabetic-Neuropathy-<br />
<strong>Market</strong>-2014-<strong>2018</strong>-110266<br />
About <strong>JSB</strong> <strong>Market</strong> Research -<br />
<strong>JSB</strong> <strong>Market</strong> Research is one of the most significant databases of online <strong>market</strong> <strong>research</strong>es and<br />
intelligence <strong>report</strong>s and services. We specialize in providing <strong>market</strong> <strong>research</strong> <strong>report</strong>s for various<br />
industries. The online portal for <strong>market</strong>ing <strong>research</strong> deals with access <strong>to</strong> global <strong>market</strong> data and<br />
assists in providing expert insights and exposure on global companies, industries, products and<br />
trends.<br />
Contact –<br />
Tel: + 91 - 22 – 41236650<br />
Website: http://www.jsb<strong>market</strong><strong>research</strong>.com<br />
Email - contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Blog: http://www.jsb<strong>market</strong><strong>research</strong>.com/blog/<br />
Email ID- contact@jsb<strong>market</strong><strong>research</strong>.com<br />
Tel No- 91 2241236650<br />
Published <strong>by</strong>- http:/www.jsb<strong>market</strong><strong>research</strong>.com/